PTC Therapeutics Inc. (PTCT) Next Earnings Date & Options-Implied ±7.4% Move
PTC Therapeutics Inc. (PTCT) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (41% profit margin, 85% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
Options-Implied Post-Earnings ±7.4% Bell Curve
Will PTCT Beat & Rip or Miss Next Quarter?
Trailing EPS: $8.18 • YoY Revenue Growth: 114.5%
Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence
| Period | Filed | Revenue | Net Profit | Free Cash Flow | Gross Margin |
|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.73B | $683.0M | $702.3M | 44% |
| FY 2024 | 2024-12-31 | $806.8M | -$363.3M | -$114.2M | 44% |
| FY 2023 | 2023-12-31 | $937.8M | -$626.6M | -$200.6M | 44% |
Whale Flow & Momentum Playbook: Trading PTCT & AI Leaders Without Chasing Tops
- ✓Exact institutional whale strikes & implied earnings range on PTCT this week
- ✓How active traders scale setups using funded prop-firm accounts instead of risking savings
- ✓Free bonus: instant RQD Rating Flip alerts on all tracked momentum leaders
PTCT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +114.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on PTCT today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for PTCT. Explore sector supply chains on /butterfly.
PTCT Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is PTCT's next earnings date?
Based on SEC filing cadence, PTC Therapeutics Inc. (PTCT)'s next quarterly earnings window is estimated around Dec 30, 2026.
How much is PTCT stock expected to move on earnings?
Options markets currently imply a ±7.4% post-earnings move for PTCT, projecting a trading range between $59.69 and $69.23.